Gene Silencing/Gene Editing
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species
The direct parental or DIPA-CRISPR method relies on injecting Cas9 ribonucleoproteins into adult females to introduce mutations into their developing oocytes.
Aldevron Gets License From Inscripta to Manufacture, Sell CRISPR Nuclease
The nuclease was released by Inscripta in 2017 free of charge to the research community and for single-digit royalties for commercial applications.
ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma
The nonexclusive licensing agreement with the Japanese drugmaker marks the 16th such deal ERS Genomics has signed in Japan.
Beyond COVID-19, Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
Premium
Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization.
ERS Genomics Licenses CRISPR IP to Central Institute for Experimental Animals
ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier.